AXDXQ — Accelerate Diagnostics Share News
0.000.00%
Last trade - 00:00- $0.00m
- $47.18m
- $11.70m
Brief: New Accelerate Pheno System Multi-Center Study Published In Clinical Infectious Diseases
Accelerate Diagnostics Inc reports results for the quarter ended in September - Earnings Summary
Brief: Accelerate Diagnostics Reports Q3 Loss Per Share Of $0.15
Brief: Accelerate Diagnostics Announces Agreements To Exchange ~$51 Million In Principal Amount Of Its 2.50% Convertible Senior Notes Due 2023 For Common Stock
Accelerate Diagnostics Inc reports results for the quarter ended in June - Earnings Summary
Brief: Accelerate Diagnostics Q2 Loss Per Share $0.36
Accelerate Diagnostics Inc expected to post a loss of 33 cents a share - Earnings Preview
Brief: Accelerate Diagnostics Announces CE Mark And Availability In Europe Of Fast Antimicrobial Susceptibility Test
U.S. RESEARCH ROUNDUP- Cree, Eagle Materials, iHeartMedia
Accelerate Diagnostics Inc reports results for the quarter ended in March - Earnings Summary
Brief: Accelerate Diagnostics Reports First Quarter 2021 Financial Results
Accelerate Diagnostics Inc expected to post a loss of 33 cents a share - Earnings Preview
Brief: Accelerate Diagnostics Reports Q4 And Full-Year 2020 Financial Results
Brief: Accelerate Diagnostics Inc Files For Mixed Shelf Of Upto $150 Million - SEC Filing
Brief: Accelerate Diagnostics Sees Q4 2020 Revenue About $3.1 Million
Brief: Accelerate Diagnostics Reports Third Quarter 2020 Financial Results
U.S. RESEARCH ROUNDUP- Accelerate Diagnostics, Honeywell, Neophotonics
Brief: Accelerate Diagnostics Announces New FDA Clearance For Accelerate PhenoTest Improvements
Accelerate Diagnostics: Rises as FDA allows emergency use of COVID-19 tests